Patents by Inventor Kjersti Flatmark

Kjersti Flatmark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PACA and cabazitaxel for anti-cancer treatment
    Patent number: 11806330
    Abstract: Described herein is an active ingredient encapsulated into poly (alkyl cyanoacrylate) nanoparticles and their use in anti-cancer treatments by intraperitoneal administration.
    Type: Grant
    Filed: March 27, 2019
    Date of Patent: November 7, 2023
    Assignees: SINTEF TTO AS, OSLO UNIVERSITETSSYKEHUS HF
    Inventors: Yrr Morch, Einar Sulheim, Kjersti Flatmark, Karianne Giller Fleten, Per Stenstad, Heidi Johnsen, Ruth Schmid
  • DRUG DELIVERY SYSTEM FOR TREATMENT OF CANCER
    Publication number: 20220257525
    Abstract: Described herein is a hydrophobic anti-cancer drug encapsulated into poly (alkyl cyanoacrylate) nanoparticles and their use in cancer treatments by intracavitary rout of administration such as intraperitoneal administration.
    Type: Application
    Filed: September 24, 2021
    Publication date: August 18, 2022
    Inventors: Yrr MORCH, Ruth SCHMID, Einar SULHEIM, Per STENSTAD, Heidi JOHNSEN, Kjersti FLATMARK, Karianne Giller FLETEN
  • IMMUNOTOXINS FOR USE IN TREATING CANCER
    Publication number: 20210147545
    Abstract: The present invention relates generally to immunotoxins. More particularly, the invention relates to immunotoxins (e.g. immunotoxins that comprise an antibody that binds to EpCAM or binds to MUC-1) for use in the treatment of cancer. The invention also relates to a method for treating cancer, said method comprising administering to a subject in need thereof a therapeutically effective amount of an immunotoxin. The invention also relates to the use an immunotoxin in the manufacture of a medicament for treating cancer.
    Type: Application
    Filed: July 24, 2018
    Publication date: May 20, 2021
    Inventors: Yvonne ANDERSSON, Øystein FODSTAD, Svein DUELAND, Kjersti FLATMARK
  • Poly (Alkyl Cyanoacrylate) Nanoparticles for Use in Treatment of Cancer
    Publication number: 20210113482
    Abstract: The invention is related to the field nanoparticles and medical use. In particular, it relates to cabazitaxel (CBZ) as active ingredient encapsulated into poly (alkyl cyanoacrylate) nanoparticles for use in treatment of cancer.
    Type: Application
    Filed: March 27, 2019
    Publication date: April 22, 2021
    Inventors: Yrr Mørch, Ruth Schmid, Einar Sulheim, Per Stenstad, Heidi Johnsen, Kirsten Sandvig, Gunhild Mælandsmo, Tore Skotland, Kjersti Flatmark
  • DRUG DELIVERY SYSTEM FOR TREATMENT OF CANCER
    Publication number: 20200061019
    Abstract: Described herein is a hydrophobic anti-cancer drug encapsulated into poly (alkyl cyanoacrylate) nanoparticles and their use in cancer treatments by intracavitary rout of administration such as intraperitoneal administration.
    Type: Application
    Filed: November 12, 2019
    Publication date: February 27, 2020
    Inventors: Yrr Morch, Einar Sulheim, KJersti Flatmark, Karianne Giller Fleten, Per Stenstad, Heidi Johnsen, Ruth Schmid
  • PACA AND CABAZITAXEL FOR ANTI-CANCER TREATMENT
    Publication number: 20190298682
    Abstract: Described herein is an active ingredient encapsulated into poly (alkyl cyanoacrylate) nanoparticles and their use in anti-cancer treatments by intraperitoneal administration.
    Type: Application
    Filed: March 27, 2019
    Publication date: October 3, 2019
    Inventors: YRR MORCH, EINAR SULHEIM, KJERSTI FLATMARK, KARIANNE GILLER FLETEN, Per Stenstad, Heidi Johnsen, Ruth Schmid
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20140248292
    Abstract: The present invention relates to compositions and methods for treating cancer. In particular, the present invention relates to EpCAM-targeted immunotoxins and uses thereof in treating peritoneal cancers expressing EpCAM (e.g., colorectal, ovarian, and pancreatic cancer).
    Type: Application
    Filed: March 4, 2014
    Publication date: September 4, 2014
    Applicant: Oslo universitetssykehus HF
    Inventors: Kjersti Flatmark, Yvonne Andersson, Oystein Fodstad
  • Method for predicting the response of locally advanced rectal cancer to chemoradiotherapy
    Patent number: 8617836
    Abstract: The present invention relates to a method for determining or predicting the response of a patient diagnosed with locally advanced rectal cancer to chemoradiotherapy. The present invention also aims to provide methods and devices for predicting the response of patients diagnosed with rectal cancer to specific medicaments, radiotherapy and/or chemotherapy. More specifically, the present invention provides methods which measure kinase activity by studying phosphorylation levels and profiles in samples of said patients.
    Type: Grant
    Filed: April 12, 2010
    Date of Patent: December 31, 2013
    Assignees: PamGene B.V., Oslo University Hospital
    Inventors: Pieter Jacob Boender, Richard De Wijn, Anne Hansen Ree, Sigurd Folkvord, Kjersti Flatmark, Robby Ruijtenbeek
  • METHOD FOR PREDICTING THE RESPONSE OF LOCALLY ADVANCED RECTAL CANCER TO CHEMORADIOTHERAPY
    Publication number: 20120135888
    Abstract: The present invention relates to a method for determining or predicting the response of a patient diagnosed with locally advanced rectal cancer to chemoradiotherapy. The present invention also aims to provide methods and devices for predicting the response of patients diagnosed with rectal cancer to specific medicaments, radiotherapy and/or chemotherapy. More specifically, the present invention provides methods which measure kinase activity by studying phosphorylation levels and profiles in samples of said patients.
    Type: Application
    Filed: April 12, 2010
    Publication date: May 31, 2012
    Inventors: Pieter Jacob Boender, Richard De Wijn, Anne Hansen Ree, Sigurd Folkvord, Kjersti Flatmark, Robby Ruijtenbeek